Herstellerprofil
Bestmade Natural Products
Pharmaunternehmen5 erfasste Produkte
5
erfasste Produkte
396.976
Meldungen insgesamt
47
dokumentierte Rückrufe
53,3%
schwerwiegend insgesamt
Produkte
Rückrufhistorie · 34 dokumentiert
| Datum | Klasse | Grund | Firma |
|---|---|---|---|
| 17. Mai 2024 | III | Labeling: Incorrect Lot and/or Expiration Date: The carton has incorrect expiration of 2026-MAY*, whereas the correct expiration date, which is on the tablet bottle label, is 2025-APR. | GlaxoSmithKline LLC |
| 2. Feb. 2024 | II | Subpotent Drug: Out of specification for assay | Bausch Health Companies, Inc. |
| 30. Sept. 2022 | II | cGMP Deviations: Out of specification for assay of one of the preservative ingredients. | VistaPharm, Inc. |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| 7. Juni 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 7. Juni 2022 | I | Microbial Contamination of Non-Sterile Products. | Plastikon Healthcare LLC |
| 7. Juni 2022 | II | CGMP Deviations: products manufactured under conditions which reflect manufacturing processes that were not adequately controlled. | Plastikon Healthcare LLC |
| 24. März 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| 24. März 2022 | I | Microbial Contamination of Non-Sterile Products | Plastikon Healthcare LLC |
| 24. März 2022 | II | CGMP Deviations: Failure to properly investigate failed microbial testing. | Plastikon Healthcare LLC |
| 24. März 2022 | II | CGMP Deviations: Failure to properly investigate failed microbial testing. | Plastikon Healthcare LLC |
| 22. Feb. 2022 | II | Impurity failure at 0-time of the repackaged lot. | American Health Packaging |
| 1. Nov. 2021 | II | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Precision Dose Inc. |
| 1. Nov. 2021 | II | cGMP Deviations: Product manufactured with contaminated raw ingredient. | Precision Dose Inc. |
| 8. März 2021 | II | Failed Impurities/Degradation Specifications; out of specification for unknown impurity observed during 6 month stability testing | Akorn, Inc. |
| 23. Juni 2020 | III | Failed impurities/degradation products; Presence of an impurity peak that exceeds the approved specification. | VistaPharm, Inc. |
| 13. Nov. 2019 | II | CGMP Deviations: Impurity N-nitrosodimethylamine (NDMA) found in API. | Precision Dose Inc. |
| 1. Nov. 2019 | II | CGMP Deviations: Presence of NDMA impurity detected in product. | American Health Packaging |
| 25. März 2019 | II | Labeling: Incorrect or Missing Lot and/or Exp Date - the label contains an incorrect Exp Date. | Lohxa LLC |
| 21. Sept. 2017 | II | Subpotent Drug:The titratable iodine contained in the Povidone-Iodine prep pads is below label claim of 0.85%. | Medline Industries Inc |
| 17. Mai 2017 | III | Failed Impurities/Degradation Specifications: Presence of an impurity peak that exceeds approved specification. | VistaPharm, Inc. |
| 8. Jan. 2016 | II | Defective Delivery System: Firm recalled Guaifenesin liquid and Guaifenesin DM liquid due incorrect dose markings on the dosing cups. | Perrigo Company PLC |
| 17. März 2015 | II | Failed Dissolution Specifications: Out of specification for dissolution of sulfamethoxazole. | Akorn, Inc. |
| 14. Nov. 2014 | II | Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin. | Attix Pharmaceuticals |
| 21. März 2013 | II | Labeling: Not Elsewhere Classified: This unit dose product is being recalled because the product's name includes the word "Children's" which is misleading since the 650 mg dose of acetaminophen contained within it, is an adult dose. | Precision Dose Inc. |
| 19. Jan. 2011 | III | Labeling: Correct Labeled Product Miscart/Mispack: The shipper label displayed "5 mL x 50," instead of "10 mL x 50," | VistaPharm, Inc. |
Klasse I = begründete Wahrscheinlichkeit schwerwiegender Schäden · Klasse II = vorübergehend oder reversibel · Klasse III = Schaden unwahrscheinlich.
Registrierungsstatus
Einige Produkte von Bestmade Natural Products sind nicht für die Anwendung am Menschen FDA-registriert. Für nicht registrierte Substanzen (Peptide, SARMs ohne Humanzulassung) existiert kein legitimer Anbieter für die Anwendung am Menschen. Das Fehlen eines Bezugswegs ist die Sicherheitsinformation.